| MT 2064 Rhodamine 123, [3H]- | |
|
HPLC
purified,
Delivered ≥ 96% pure with dated HPLC radiochromatogram
|
|
| Ethanol solution, 1 mCi/ml | |
| >5 Ci(185 GBq)/mmol | 50 μCi (1.85 MBq) $1160 |
| NextGen V-Vial - shipped on dry ice | 250 μCi (9.25 MBq) $1970 |
M.W. 380.83  | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
|
MT 1939 Rhodamine
6G, [3H]- Click here for Typical Certificate of Analysis |
|
|
HPLC
purified,
Delivered ≥ 96% pure with dated HPLC radiochromatogram
|
|
| Ethanol solution, 1 mCi/ml | |
| ≥200 mCi(7.4 GBq)/mmol | 50 μCi (1.85 MBq) $1160 |
| NextGen V-Vial - shipped on dry ice | 250 μCi (9.25 MBq) $1970 |
M.W. 479.01  | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
| MT 2065 Rhodamine B, [3H]- | |
|
HPLC
purified,
Delivered ≥ 96% pure with dated HPLC radiochromatogram
|
|
| Ethanol solution, 1 mCi/ml | |
| ≥200 mCi(7.4 GBq)/mmol | Please Inquire for Pricing |
| NextGen V-Vial - shipped on dry ice | |
M.W. 479.01 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |